References
- Wang LY, Liang DC, Liu HC, et al. Alloimmunization among patients with transfusion-dependent thalassemia in Taiwan. Transfus Med 2006;16:200–3.
- Zaidi U, Borhany M, Ansari S, et al. Red cell alloimmunisation in regularly transfused beta thalassemia patients in Pakistan. Transfus Med 2015;25:106–10.
- Elhence P, Solanki A, Verma A. Red blood cell antibodies in thalassemia patients in northern India: risk factors and literature review. Indian J Hematol Blood Transfus 2014;30:301–8.
- Spanos T, Karageorga M, Ladis V, Peristeri J, Hatziliami A, Kattamis C. Red cell alloantibodies in patients with thalassemia. Vox Sang 1990;58:50–5.
- Al-Riyami AZ, Al-Muqbali A, Al-Sudiri S, et al. Risks of red blood cell alloimmunization in transfusion-dependent beta-thalassemia in Oman: a 25-year experience of a university tertiary care reference center and a literature review. Transfusion 2018;58:871–8.
- Abdelrazik AM, Elshafie SM, El Said MN, et al. Study of red blood cell alloimmunization risk factors in multiply transfused thalassemia patients: role in improving thalassemia transfusion practice in Fayoum, Egypt. Transfusion 2016;56: 2303–7.
- Fucharoen S, Taphaichitr VS, Torcharus K, Viprakasit V. Clinical practice guidelines for diagnosis and management of thalassemia symdromes (in Thai). Bangkok, Thailand: P.A. Living, 2014.
- Fasano RM, Chou ST. Red blood cell antigen genotyping for sickle cell disease, thalassemia, and other transfusion complications. Transfus Med Rev 2016;30:197–201.
- Dhawan HK, Kumawat V, Marwaha N, et al. Alloimmunization and autoimmunization in transfusion dependent thalassemia major patients: study on 319 patients. Asian J Transfus Sci 2014;8:84–8.
- Thedsawad A, Taka O, Wanachiwanawin W. Prevalence and clinical significances of red cell alloimmunization and red cell bound immunoglobulin G in polytransfused patients with thalassemias. Hematology (Amsterdam, Netherlands) 2019;24:208–14.
- Singer ST, Wu V, Mignacca R, Kuypers FA, Morel P, Vichinsky EP. Alloimmunization and erythrocyte autoimmunization in transfusion-dependent thalassemia patients of predominantly Asian descent. Blood 2000;96:3369–73.
- Ameen R, Al-Shemmari S, Al-Humood S, Chowdhury RI, Al-Eyaadi O, Al-Bashir A. RBC alloimmunization and autoimmunization among transfusion-dependent Arab thalassemia patients. Transfusion 2003;43:1604–10.
- Pahuja S, Pujani M, Gupta SK, Chandra J, Jain M. Alloimmunization and red cell autoimmunization in multitransfused thalassemics of Indian origin. Hematology (Amsterdam, Netherlands) 2010;15:174–7.
- Romphruk AV, Simtong P, Butryojantho C, et al. The prevalence, alloimmunization risk factors, antigenic exposure, and evaluation of antigen-matched red blood cells for thalassemia transfusions: a 10-year experience at a tertiary care hospital. Transfusion 2019;59:177–84.
- Trompeter S, Cohen A, Porter J. Blood transfusion. In: Cappellini MD, Cohen A, Porter J, Taher A, Viprakasit V, Eds. Guidelines for the management of transfusion dependent thalassemia (TDT). 3rd ed. Thalassemia International Federation TIF Publication No. 20; 2014:28–41.
- National Healthcare Safety Network Biovigilance Component Hemovigilance Module Surveillance Protocol v2.5.2. Atlanta, GA: U.S. Centers for Disease Control and Prevention. April 2018.Available from www.cdc.gov/nhsn.
- Matteocci A, Pierelli L. Red blood cell alloimmunization in sickle cell disease and in thalassaemia: current status, future perspectives and potential role of molecular typing. Vox Sanguinis 2014;106:197–208.
- Hendrickson JE, Tormey CA. Understanding red blood cell alloimmunization triggers. Hematology Am Soc Hematol Educ Program. 2016;2016:446–51.
- Yazdanbakhsh K, Ware RE, Noizat-Pirenne F. Red blood cell alloimmunization in sickle cell disease: pathophysiology, risk factors, and transfusion management. Blood 2012;120: 528–37.
- Rujirojindakul P, Flegel WA. Applying molecular immunohaematology to regularly transfused thalassaemic patients in Thailand. Blood Transfus 2014;12:28–35.
- Yee MEM, Josephson CD, Winkler AM, et al. Red blood cell minor antigen mismatches during chronic transfusion therapy for sickle cell anemia. Transfusion 2017;57:2738–46.
- Cheng CK, Lee CK, Lin CK. Clinically significant red blood cell antibodies in chronically transfused patients: a survey of Chinese thalassemia major patients and literature review. Transfusion 2012;52:2220–4.
- Luban NL. Variability in rates of alloimmunization in different groups of children with sickle cell disease: effect of ethnic background. Am J Pediatr Hematol Oncol 1989;11:314–9.
- Shaz BH, Hillyer CD. Minority donation in the United States: challenges and needs. Current Opin Hematol 2010;17:544–9.